FDA’s Independent Advisory Panel Votes in Favor of Two RSV Vaccines March 2, 2023 The FDA’s independent advisory panel voted in favor of two vaccines for respiratory syncytial virus (RSV). The vaccines, developed by GSK and Pfizer for people Read More »
Today’s Infectious Disease News (2/22/23) February 22, 2023 First RSV Vaccine Could Be Approved by August The world’s first vaccine for RSV, or respiratory syncytial virus, could be approved by August 2023. The Read More »